Cancer Cell Stocks List

Recent Signals

Date Stock Signal Type
2021-05-11 CRIS Pocket Pivot Bullish Swing Setup
2021-05-11 CRIS New Downtrend Bearish
2021-05-11 CRVS Lower Bollinger Band Walk Weakness
2021-05-11 CRVS New 52 Week Closing Low Bearish
2021-05-11 CRVS New 52 Week Low Weakness
2021-05-11 CRVS MACD Bearish Signal Line Cross Bearish
2021-05-11 CYCC Bullish Engulfing Bullish
2021-05-11 CYCC Bollinger Band Squeeze Range Contraction
2021-05-11 DFFN Fell Below 20 DMA Bearish
2021-05-11 ERYP Bollinger Band Squeeze Range Contraction
2021-05-11 FBIO Stochastic Buy Signal Bullish
2021-05-11 IOVA Lower Bollinger Band Walk Weakness
2021-05-11 IOVA New 52 Week Closing Low Bearish
2021-05-11 IOVA Stochastic Buy Signal Bullish
2021-05-11 KZIA Pocket Pivot Bullish Swing Setup
2021-05-11 KZIA Stochastic Buy Signal Bullish
2021-05-11 MACK Stochastic Buy Signal Bullish
2021-05-11 MBIO Bollinger Band Squeeze Range Contraction
2021-05-11 NCNA NR7 Range Contraction
2021-05-11 NCNA Lower Bollinger Band Walk Weakness
2021-05-11 RFL Upper Bollinger Band Walk Strength
2021-05-11 RIGL Crossed Above 200 DMA Bullish
2021-05-11 RIGL Stochastic Buy Signal Bullish
2021-05-11 SNDX Non-ADX 1,2,3,4 Bearish Bearish Swing Setup

Recent News for Cancer Cell Stocks

Date Stock Title
May 12 FBIO Checkpoint Therapeutics Announces Completion of Enrollment in the Registration-Enabling Trial of Cosibelimab in Metastatic Cutaneous Squamous Cell Carcinoma
May 12 CYCC Earnings Scheduled For May 12, 2021
May 12 CRIS Earnings Scheduled For May 12, 2021
May 12 SNDX Syndax Pharmaceuticals, Inc. (SNDX) CEO Dr. Briggs Morrison on Q1 2021 Results - Earnings Call Transcript
May 11 SNDX Syndax Pharmaceuticals, Inc. 2021 Q1 - Results - Earnings Call Presentation
May 11 SNDX Recap: Syndax Pharmaceuticals Q1 Earnings
May 11 SNDX Syndax Pharma announces new data for SNDX-5613 in trial for acute leukemias
May 11 SNDX Syndax Pharmaceuticals EPS beats by $0.13, beats on revenue
May 11 SNDX Syndax Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Clinical and Business Update
May 11 SNDX Syndax Pharmaceuticals, Inc. to Host Earnings Call
May 11 SNDX Earnings Scheduled For May 11, 2021
May 10 DFFN Diffusion Pharma's Trans Sodium Crocetinate Associated With Improved Outcomes In COVID-19 Patients
May 10 MBIO FDA accepts Mustang Bio's MB-106 application in cancer
May 10 DFFN Diffusion Pharma gains 17% on final TSC data in hospitalized COVID-19 patients
May 10 ONTX Onconova Therapeutics to Provide Corporate Update and Announce First Quarter 2021 Financial Results on May 17, 2021
May 10 DFFN Diffusion Pharmaceuticals EPS misses by $0.02
May 10 DFFN Diffusion Pharmaceuticals Reports Final Results from Its Phase 1b Study of Trans Sodium Crocetinate in Hospitalized COVID-19 Patients
May 10 MBIO Mustang Bio Announces FDA Acceptance of IND Application for MB-106, a CD20-Targeted CAR T Therapy
May 10 FBIO Mustang Bio Announces FDA Acceptance of IND Application for MB-106, a CD20-Targeted CAR T Therapy
May 10 DFFN Diffusion Pharmaceuticals Reports First Quarter Financial Results and Provides Business Update

Cancer cells are cells that divide relentlessly, forming solid tumors or flooding the blood with abnormal cells. Cell division is a normal process used by the body for growth and repair. A parent cell divides to form two daughter cells, and these daughter cells are used to build new tissue or to replace cells that have died because of aging or damage. Healthy cells stop dividing when there is no longer a need for more daughter cells, but cancer cells continue to produce copies. They are also able to spread from one part of the body to another in a process known as metastasis.

More about Cancer Cell
Browse All Tags